Compare PRHI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRHI | IRIX |
|---|---|---|
| Founded | 2009 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7M | 15.0M |
| IPO Year | 2015 | 1996 |
| Metric | PRHI | IRIX |
|---|---|---|
| Price | $6.97 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.2K | ★ 673.9K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $43,304,000.00 | $41,593,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | $4.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $0.61 |
| 52 Week High | $10.99 | $1.65 |
| Indicator | PRHI | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 50.28 |
| Support Level | $4.05 | $0.64 |
| Resistance Level | $7.95 | $1.00 |
| Average True Range (ATR) | 0.69 | 0.11 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 11.68 | 28.01 |
Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.